Alhasan, SA, Aranha, O &Sarkar, FHGenistein elicits pleiotropic molecular effects on head and neck cancer cells. Clin Cancer Res 2001 7, 4174–4181.
Aprelikova, ON, Fang, BS, Meissner, EG, Cotter, S, Campbell, M, Kuthiala, A, Bessho, M, Jensen, RA & Liu, ET (1999) BRCA1-associated growth arrest is RB-dependent. Proc Natl Acad Sci USA. 96, 11886–11871.
Arai, Y, Watanabe, S, Kimira, M, Shimoi, K, Mochizuki, R & Kinae, NDietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration J Nutr 2000 130, 2243–2250.
Balabhadrapathruni, S, Thomas, TJ, Yurkow, EJ, Amenta, PS & Thomas, TEffects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells Oncol Rep. 2000 7, 3–12
Barnes, S & Peterson, TGBiochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med 1995 208, 103–108
Bernard-Gallon, DJ, Maurizis, JC, Rio, PG & Bignon, YJInfluence of genistein and daidzein on Brca1 protein levels in human breast cell lines. J Natl Cancer Inst 1998 90, 862–863.
Bernard-Gallon, DJ, Vissac-Sabatier, C, Antoine-Vincent, D, Rio, PG,Maurizis, JC, Fustier, P& Bignon, YJDifferential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines. Br J Nutr 2002 87, 281–289.
Cailleau, R, Young, R, Olive, M & Reeves, WJ JrBreast tumor cell lines from pleural effusions. J Natl Cancer Inst 1974 53, 661–674.
Chen, J, Silver, DP, Walpita, D, Cantor, SB, Gazdar, AF, Tomlinson, G, Couch, FJ, Weber, BL, Ashley, T, Livingston, DM & Scully, RStable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells Mol Cell 1998 2, 317–328.
Chen, Z, Zheng, W, Custer, LJ, Dai, Q, Shu, XO, Jin, F & Franke, AAUsual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai Nutr Cancer 1999 33, 82–87.
Choi, YH, Zhang, L, Lee, WH & Park, KYGenistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int J Oncol 1998 13, 391–396
Claus, EB, Risch, N & Thompson, WDGenetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991 48, 232–242
Coward, L, Kirk, M, Albin, N & Barnes, SAnalysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin Chim Acta 1996 247, 121–142.
Dai, Q, Shu, XO, Jin, F, Potter, JD, Kushi, LH, Teas, J, Gao, YT & Zheng, WPopulation-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 2001 85, 372–378.
Fan, S, Ma, YX, Wang, C et al. . Role of direct interaction in BRCA1 inhibition of estrogen receptor activity Oncogene 2001 20. 77–87.
Fan, S, Ma, YX, Wang, C et al. . p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res 2002 62, 141–151.
Favy, DA, Lafarge, S, Rio, P, Vissac, C, Bignon, YJ & Bernard-Gallon, DReal-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines. Biophys Res Commun 2000 274, 7378.
Fink, L, Seeger, W, Ermert, W, Hanze, J, Stahl, U, Grimminger, F, Kummer, W & Bohle, RMReal-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 1998 4, 1329–1333.
Fioravanti, L, Cappelletti, V, Miodini, P, Ronchi, E, Brivio, M & DiFronzo, GGenistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett 1998 130, 143–152.
Fotsis, T, Pepper, M, Adlercreutz, H, Fleischmann, G, Hase, T & Montesano, R, Schweigerer, LGenistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 1993 90, 2690–2694.
Futreal, PA, Liu, Q, Shattuck-Eidens, D et al. . BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994 266, 120–122.
Grace, PB, Taylor, JI, Low, YL et al. . Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomarkers Prev 2004 13, 698–708.
Greenstein, JKushi, L, Zheng, W, Fee, R, Campbell, D, Sellers, T & Folsom, ARisk of breast cancer associated with intake of specific foods and food groups. Am J Epidemiol 1996 143, s36.
Hirose, K, Tajima, K, Hamajima, N, Inoue, M, Takezaki, T, Kuroishi, TYoshida, M & Tokudome, SA large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res 1995 86, 146–154.
Hong, SJ, Kim, SI, Kwon, SM, Lee, JR & Chung, BCComparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Med J 2002 43, 236–241.
Horn-Ross, PL, John, EM, Lee, M, Stewart, SL, Koo, j, Sakoda, LC, Shiau, AC, Goldstein, j, Davis, p & Perez-Stable, EJPhytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 2001 154, 434–441.
Horn-Ross, PL, Lee, M, John, EM & Koo, TSources of phytoestrogen exposure among non-Asian women in California, USA. Cancer Causes Control. 2000 11, 299–302.
Hsieh, CY, Santell, RC, Haslam, SZ & Helferich, WGEstrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998 58, 3833–3838.
Izumi, T, Piskula, MK, Osawa, S, Obata, A, Tobe, K, Saito, M, Kataoka, S, Kubota, Y & Kikuchi, MSoy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 2000 130, 1695–1699.
Jin, S, Tong, T, Fan, W et al. . GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene 2002 21, 8696–8704.
Keinan-Boker, L, Peeters, PH, Mulligan, AA et al. . Soy product consumption in 10 European countries: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2002 5, 1217–1226.
Kim, H, Peterson, TG & Barnes, SMechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr 1998 68, 1418S–1425S.
King, RA & Bursill, DBPlasma and urinary kinetics of the iso-flavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr 1998 67, 867–872.
Kuiper, GG, Carlsson, B, Grandien, K, Enmark, E, Haggblad, J, Nilsson, S & Gustafsson, JAComparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997 138, 863–870.
Kuiper, GG, Lemmen, JG, Carlsson, B, Corton, JC, Safe, SH, van, der, Saag, PT, van, derBurg, B & Gustafsson, JAInteraction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998 139, 4252–4263
Lamartiniere, CA, Cotroneo, MS, Fritz, WA, Wang, JMentor-Marcel, R & Elgavish, AGenistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 2002 132, 552S–558S.
Lamartiniere, CA, Moore, J, Holland, M & Barnes, SNeonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 1995 208, 120–123.
Le Bail, JC, Varnat, F, Nicolas, JC & Habrioux, GEstrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett 1998 130, 209–216.
Le Corre, L, Fustier, P, Chalabi, N, Bignon, YJ & Bernard-Gallon, DEffects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines. Clin Chim Acta 2004 344, 115–121.
Lee, HP, Gourley, L, Duffy, SW, Esteve, J, Lee, J & Day, NEDietary effects on breast-cancer risk in Singapore. Lancet 1991 337, 1197–1200.
Li, Y, Upadhyay, S, Bhuiyan, M & Sarkar, FHInduction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 1999 18, 3166–3172.
Maggiolini, M, Bonofiglio, D, Marsico, S,Panno, ML, Cenni, B, Picard, D & Ando, SEstrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol 2001 60, 595
Marks, JR, Huper, G, Vaughn, JP, Davis, PL, Norris, J, McDonnell, DP, Wiseman, RW, Futreal, PA & Iglehart, JDBRCA1 expression is not directly responsive to estrogen. Oncogene 1997 14, 115–121.
Miki, Y, Swensen, J, Shattuck-Eidens, D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994 266, 66–71.
Morris, SM, Chen, JJ, Domon, OE,McGarrity, LJBishop, ME, Manjanatha, MG & Casciano, DAp53, mutations, and apoptosis in genistein-exposed human lymphoblastoid cells. Mutat Res 1998 405, 41–56.
Neuteboom, ST, Karjian, PL, Boyer, CR, Beryt, M, Pegram, M, Wahl, GM & Shepard, HMInhibition of cell growth by NB1011 requires high thymidylate synthase levels and correlates with p53, p21, bax, and GADD45 induction. Mol Cancer Ther 2002 1, 377–384.
Nomoto, S, Arao, Y, Horiguchi, H,Ikeda, K & Kayama, FOestrogen causes G2/M arrest and apoptosis in breast cancer cells MDA-MB-231. Oncol Rep 2002 9, 773–776
Pao, GM, Janknecht, R, Ruffner, H, Hunter, T & Verma, IMCBP/p300 interact with and function as transcriptional coactivators of BRCA1 Proc Natl Acad Sci USA 2000 97, 1020–1025.
Peterson, GEvaluation of the biochemical targets of genistein in tumor cells. J Nutr 1995 125, 784S–789S
Sathyamoorthy, N & Wang, TTDifferential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells Eur J Cancer 1997 33, 2384–2389.
Shao, ZM, Alpaugh, ML, Fontana, JA & Barsky, SHGenistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis J Cell Biochem 1998 69, 44–54.
Shu, XO, Jin, F, Dai, Q, Wen, W, Potter, JD, Kushi, LH, Ruan, Z, Gao, YT & Zheng, WSoyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2001 10, 483–488.
Soule, HDMaloney, TMWolman, SRPeterson, WD JrBrenz, RMcGrath, CMRusso, JPauley, RJJones, RF&Brooks, SCIsolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990 50 6075–6086
Soule, HDVazguez, JLong, AAlbert, S&Brennan, MA human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973 51 1409–1416
Spillman, MA&Bowcock, AMBRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene 1996 13 1639–1645
Srivastava, SWeitzmann, MNCenci, SRoss, FPAdler, S &Pacifici, REstrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest 1999 104 503–513
Takahashi, YLavigne, JAHursting, SDChandramouli, GVPerkins, SNBarrett, JC &Wang, TTUsing DNA microarray analyses to elucidate the effects of genistein in androgen-responsive prostate cancer cells: identification of novel targets. Mol Carcinog 2004 41 108–119
Thompson, MEJensen, RAObermiller, PSPage, DL & Holt, JTDecreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 1995 9 444–450
Vissac-Sabatier, CBignon, Y-J&Bernard-Gallon, DJEffects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppress or gene expression in breast cell lines Nutr Cancer 2003 45 247–255
Welcsh, PLOwens, KN&King, MCInsights into the functions of BRCA1 and BRCA2. Trends Genet 2000 16 69–74
Witte, JSUrsin, GSiemiatycki, JThompson, WDPaganini-Hill, A&Haile, RWDiet and premenopausal bilateral breast cancer: a case-control study Breast Cancer Res Treat 1997 42 243–251
Wooster, RBignell, GLancaster, JSwift, SSeal, SMangion, JCollins, NGregory, SGumbs, C & Micklem, GIdentification of the breast cancer susceptibility gene BRCA2. Nature 1995 378 789–792
Wu, AHZiegler, RGHorn-Ross, PLNomura, AMWest, DWKolonel, LNRosenthal, JFHoover, RN &Pike, MCTofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 1996 5 901–906
Xu, XWang, HJMurphy, PACook, L &Hendrich, SDaidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 1994 124 825–832
Yuan, JMWang, QSRoss, RKHenderson, BE&Yu, MCDiet and breast cancer in Shanghai and Tianjin, China Br J Cancer 1995 71 1353–1358
Zava, DT&Duwe, GEstrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 1997 27 31–40
Zhang, HSomasundaram, KPeng, YTian, HBi, DWeber, BL&El-Deiry, WSBRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 1998 16 1713–1721